Ilaria Zanetti

2.4k total citations
46 papers, 1.3k citations indexed

About

Ilaria Zanetti is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Ilaria Zanetti has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 26 papers in Pathology and Forensic Medicine and 16 papers in Surgery. Recurrent topics in Ilaria Zanetti's work include Sarcoma Diagnosis and Treatment (43 papers), Tumors and Oncological Cases (18 papers) and Surgical site infection prevention (9 papers). Ilaria Zanetti is often cited by papers focused on Sarcoma Diagnosis and Treatment (43 papers), Tumors and Oncological Cases (18 papers) and Surgical site infection prevention (9 papers). Ilaria Zanetti collaborates with scholars based in Italy, Netherlands and France. Ilaria Zanetti's co-authors include Gianni Bisogno, Andrea Ferrari, Michela Casanova, Modesto Carli, Rita Alaggio, Giovanni Cecchetto, Daniel Orbach, Gian Luca De Salvo, Anna Kelsey and Johannes H. M. Merks and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Ilaria Zanetti

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilaria Zanetti Italy	20	969	446	426	372	356	46	1.3k
Alvida M. Cain United States	20	911 0.9×	287 0.6×	310 0.7×	179 0.5×	313 0.9×	30	1.4k
Stephen Weiss United States	10	643 0.7×	431 1.0×	213 0.5×	326 0.9×	258 0.7×	10	1.2k
Yun-Shao Sung United States	20	1.3k 1.4×	625 1.4×	388 0.9×	246 0.7×	239 0.7×	22	1.8k
Toru Motoi Japan	22	1.2k 1.2×	753 1.7×	358 0.8×	143 0.4×	277 0.8×	103	1.9k
Beverly Raney United States	19	925 1.0×	405 0.9×	331 0.8×	168 0.5×	376 1.1×	32	1.2k
Hirokazu Chuman Japan	25	1.1k 1.1×	542 1.2×	236 0.6×	122 0.3×	530 1.5×	73	1.6k
Ines B. Brecht Germany	18	480 0.5×	143 0.3×	237 0.6×	164 0.4×	450 1.3×	76	1.1k
Anne Sophie Defachelles France	22	523 0.5×	158 0.4×	298 0.7×	410 1.1×	309 0.9×	83	1.4k
Tobias M. Dantonello Germany	18	779 0.8×	312 0.7×	294 0.7×	75 0.2×	270 0.8×	37	935
Hugo Domínguez‐Malagón Mexico	18	405 0.4×	321 0.7×	196 0.5×	103 0.3×	238 0.7×	51	982

Countries citing papers authored by Ilaria Zanetti

Since Specialization

Citations

This map shows the geographic impact of Ilaria Zanetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilaria Zanetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilaria Zanetti more than expected).

Fields of papers citing papers by Ilaria Zanetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilaria Zanetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilaria Zanetti. The network helps show where Ilaria Zanetti may publish in the future.

Co-authorship network of co-authors of Ilaria Zanetti

This figure shows the co-authorship network connecting the top 25 collaborators of Ilaria Zanetti. A scholar is included among the top collaborators of Ilaria Zanetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilaria Zanetti. Ilaria Zanetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bisogno, Gianni, Véronique Minard‐Colin, Ilaria Zanetti, et al.. (2024). Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial. Pediatric Blood & Cancer. 72(2). e31436–e31436. 4 indexed citations

Bisogno, Gianni, Véronique Minard‐Colin, Ilaria Zanetti, et al.. (2023). Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study. Journal of Clinical Oncology. 41(13). 2342–2349. 21 indexed citations

Ferrari, Andrea, Daniel Orbach, Michela Casanova, et al.. (2023). Metastatic adult‐type non‐rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group. Cancer. 129(16). 2542–2552. 7 indexed citations

Guérin, Florent, Hélène Martelli, Timothy Rogers, et al.. (2023). Outcome of patients with undifferentiated embryonal sarcoma of the liver treated according to European soft tissue sarcoma protocols. Pediatric Blood & Cancer. 70(7). e30374–e30374. 8 indexed citations

Rogers, Timothy, Ilaria Zanetti, Hélène Martelli, et al.. (2022). Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies. Pediatric Blood & Cancer. 69(9). e29739–e29739. 6 indexed citations

Orbach, Daniel, Max M. van Noesel, Bernadette Brennan, et al.. (2022). Epithelioid hemangioendothelioma in children: The European Pediatric Soft Tissue Sarcoma Study Group experience. Pediatric Blood & Cancer. 69(10). e29882–e29882. 4 indexed citations

Ben-Arush, Myriam, Véronique Minard‐Colin, Giovanni Scarzello, et al.. (2022). Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group. European Journal of Cancer. 172. 119–129. 8 indexed citations

Poli, Elena, Manuela Cattelan, Luisa Santoro, et al.. (2022). Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness. OncoImmunology. 11(1). 2096349–2096349. 4 indexed citations

Slater, Olga, J. Gains, Anna Kelsey, et al.. (2021). Localised rhabdomyosarcoma in infants (<12 months) and young children (12–36 months of age) treated on the EpSSG RMS 2005 study. European Journal of Cancer. 160. 206–214. 13 indexed citations

10.

Rogers, Timothy, Federica De Corti, Gabriela Guillén, et al.. (2020). Paratesticular rhabdomyosarcoma—Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG). Pediatric Blood & Cancer. 67(9). e28479–e28479. 13 indexed citations

11.

Morosi, Carlo, Chiara Giraudo, Filippo Crimì, et al.. (2020). Pediatric Rhabdomyosarcomas: Three-Dimensional Radiological Assessments after Induction Chemotherapy Predict Survival Better than One-Dimensional and Two-Dimensional Measurements. Cancers. 12(12). 3808–3808. 11 indexed citations

12.

Brennan, Bernadette, Ilaria Zanetti, Gian Luca De Salvo, et al.. (2020). Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). Pediatric Blood & Cancer. 67(10). e28351–e28351. 13 indexed citations

13.

Bisogno, Gianni, Gian Luca De Salvo, Christophe Bergeron, et al.. (2019). Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 20(11). 1566–1575. 149 indexed citations

14.

Spunt, Sheri L., Nadine Francotte, Gian Luca De Salvo, et al.. (2019). Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials. European Journal of Cancer. 112. 98–106. 16 indexed citations

15.

Noesel, Max M. van, Daniel Orbach, Bernadette Brennan, et al.. (2019). Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS‐2005 prospective study. Pediatric Blood & Cancer. 66(10). e27833–e27833. 42 indexed citations

16.

Bisogno, Gianni, Kieran McHugh, Hervé J. Brisse, et al.. (2019). Indeterminate Pulmonary Nodules at Diagnosis in Rhabdomyosarcoma: Are They Clinically Significant? A Report From the European Paediatric Soft Tissue Sarcoma Study Group. Journal of Clinical Oncology. 37(9). 723–730. 23 indexed citations

17.

Affinita, Maria Carmen, Michela Casanova, Giuseppe Maria Milano, et al.. (2018). Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee. Tumori Journal. 105(2). 138–143. 9 indexed citations

18.

Brennan, Bernadette, Ilaria Zanetti, Daniel Orbach, et al.. (2017). Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005). Pediatric Blood & Cancer. 65(4). 21 indexed citations

19.

Ferrari, Andrea, Gianni Bisogno, Michela Casanova, et al.. (2002). Paratesticular Rhabdomyosarcoma: Report From the Italian and German Cooperative Group. Journal of Clinical Oncology. 20(2). 449–455. 50 indexed citations

20.

Alaggio, Rita, Patrizia Dall’Igna, Gianni Bisogno, et al.. (2001). Fibrosarcoma in pediatric patients: Results of the Italian Cooperative Group studies (1979–1995). Journal of Surgical Oncology. 78(4). 225–231. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact